Skip to content
PeptideAgent

Are peptides legal in Rhode Island?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A Rhode Island resident can obtain FDA approved peptides such as semaglutide and tirzepatide from any Rhode Island-licensed prescriber, including through telemedicine under Rhode Island General Laws section 5-37-22 and the Telemedicine Coverage Act (chapter 27-81), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Rhode Island Department of Health, which houses the Board of Pharmacy, or holding a Rhode Island nonresident pharmacy license. Rhode Island has no state bulks list, so eligibility of a peptide for compounding follows the FDA framework, and the Department of Health's pharmacy regulations (216-RICR-40-15) govern how licensed pharmacies compound.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Rhode Island resident get peptides by telehealth?

Rhode Island General Laws section 5-37-22 sets the practice standard for physicians using telemedicine: a physician-patient relationship may be established through telemedicine, the physician must be licensed in Rhode Island, the standard of care is the same as for in-person care, and the physician may issue a prescription from a telemedicine encounter subject to federal and state controlled substance law. The Telemedicine Coverage Act (chapter 27-81) defines telemedicine for coverage purposes and, after 2021 amendments, includes audio-only and store-and-forward modalities. Rhode Island is a member of the Interstate Medical Licensure Compact. Because the peptides in this database are not controlled substances, the federal in-person requirement for telemedicine prescribing of controlled substances does not apply. [1] [3] [4] [14]

How does the Rhode Island pharmacy board treat compounding?

Compounding regulator for Rhode Island
BoardRhode Island Board of Pharmacy (Rhode Island Department of Health)
Eligible substancesFollows the federal 503A framework

The Board of Pharmacy sits within the Rhode Island Department of Health. Under Rhode Island General Laws section 5-19.1-5 the Board, subject to the Director of Health's approval, regulates pharmacy practice and adopts rules, and the Department issues pharmacy licenses under chapter 5-19.1 (Pharmacies). The Department's regulation 216-RICR-40-15-1 (Pharmacists, Pharmacies, and Manufacturers, Wholesalers, and Distributors, current version effective April 12, 2026) covers compounding in section 1.8 (Compounding of Pharmaceuticals) and, in section 1.2, incorporates USP chapter 797 (sterile, 2023), chapter 795 (non-sterile, 2023), and chapter 800 (hazardous drugs, 2020) by reference. Rhode Island has not adopted a separate list of compoundable bulk substances; a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). Section 5-19.1-11 makes any pharmacy outside Rhode Island that ships, mails, or delivers legend drugs or devices into the state a nonresident pharmacy that must be licensed by the Department, keep a valid home-state license, and follow Rhode Island pharmacy regulations when dispensing to Rhode Island residents; section 1.7.3 of 216-RICR-40-15-1 adds licensure conditions, including a Rhode Island agent for service of process. The Department's license lookup confirms a pharmacy's license. [2] [5] [6] [7] [9]

Can you get compounded GLP-1s in Rhode Island?

Regulatory: Compounded GLP-1 limited

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Rhode Island pharmacy or nonresident pharmacy license. [1] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Rhode Island?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in Rhode Island

Is it legal to buy research peptides in Rhode Island?

Rhode Island General Laws chapter 5-19.1 restricts dispensing of prescription drugs to licensed pharmacies, and the Rhode Island Food, Drugs, and Cosmetics Act (chapter 21-31) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the state. [5] [8] [13]

Peptide-specific notes for Rhode Island

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Rhode Island through telemedicine?

Yes. Section 5-37-22 allows a Rhode Island-licensed physician to establish a relationship and prescribe through telemedicine when the care meets the in-person standard. Semaglutide and tirzepatide are not controlled substances, so no separate in-person requirement applies. [3] [4]

Does the telemedicine prescriber need a Rhode Island license?

Yes. Section 5-37-22 applies to physicians licensed in Rhode Island, and the Department of Health licenses nurse practitioners and physician assistants who prescribe. Rhode Island is a member of the Interstate Medical Licensure Compact. Verify the prescriber in the Department of Health license lookup before paying. [1] [3] [14]

Can an out-of-state pharmacy ship compounded peptides to me in Rhode Island?

Only if it holds a Rhode Island nonresident pharmacy license. Section 5-19.1-11 requires any pharmacy outside Rhode Island that ships legend drugs into the state to be licensed by the Department of Health, and section 1.7.3 of 216-RICR-40-15-1 sets the licensure conditions. Search the Department of Health license verification for the pharmacy name; if it is not listed, the shipment is not lawful in Rhode Island even if the prescriber is compliant. [2] [6] [7]

Can a Rhode Island pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [10] [11]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]Rhode Island Department of Health (Board of Pharmacy and professional licensing)
  2. [2]Rhode Island Department of Health: Pharmacy licensing (Board of Pharmacy)
  3. [3]Rhode Island General Laws section 5-37-22, Telemedicine
  4. [4]Rhode Island General Laws chapter 27-81, Telemedicine Coverage Act
  5. [5]Rhode Island General Laws chapter 5-19.1, Pharmacies
  6. [6]Rhode Island General Laws section 5-19.1-11, Nonresident pharmacy
  7. [7]216-RICR-40-15-1, Pharmacists, Pharmacies, and Manufacturers, Wholesalers, and Distributors (Rhode Island Department of Health regulations)
  8. [8]Rhode Island General Laws chapter 21-31, Rhode Island Food, Drugs, and Cosmetics Act
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in Rhode Island?. https://peptideagent.ai/legal/rhode-island
HTML link
<a href="https://peptideagent.ai/legal/rhode-island">Are peptides legal in Rhode Island?</a>, PeptideAgent, updated September 22, 2026.